Literature DB >> 19084907

Phosphorylation of GluR1, ERK, and CREB during spontaneous withdrawal from chronic heroin self-administration.

Scott Edwards1, Danielle L Graham, Kimberly N Whisler, David W Self.   

Abstract

Negative motivational symptoms are observed soon after withdrawal from chronic opiate administration, and are thought to mediate dependence. Examination of brain region-specific signaling changes that accompany early withdrawal may shed light on neural mechanisms underlying negative reinforcement and dependence. Thus, we measured alterations in protein phosphorylation in multiple limbic brain regions in rats undergoing 24 h spontaneous or naltrexone-precipitated withdrawal from chronic (6 h/day) i.v. heroin self-administration. Region-specific increases in cyclic AMP-dependent GluR(1) (S845) phosphorylation were found in the nucleus accumbens shell, basolateral amygdala, hippocampal CA1 and CA3 subregions, and premotor cortex from 12 to 24 h of spontaneous withdrawal, and there were no changes in prefrontal cortex, nucleus accumbens core or caudate-putamen. Increased GluR(1) (S845) phosphorylation was detected earlier (12 h withdrawal) in the central amygdala and ventral tegmental area. In contrast, prominent increases in extracellular signal-regulated kinase phosphorylation were found in both prefrontal and premotor cortex, and CA1 and CA3 between 12 and 24 h withdrawal. Phosphorylation of striatal cyclic AMP response element binding protein increased in the caudate-putamen but not in the nucleus accumbens. Naltrexone administration after 24 h withdrawal increased extracellular signal-regulated kinase phosphorylation in the central amygdala, and nucleus accumbens core and shell. Thus, spontaneous withdrawal from heroin self-administration produces region- and time-dependent changes in cyclic AMP and extracellular signal-regulated kinase activity that could contribute to the behavioral manifestation of opiate dependence. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19084907      PMCID: PMC2628418          DOI: 10.1002/syn.20601

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  67 in total

Review 1.  The role of the striatopallidal and extended amygdala systems in drug addiction.

Authors:  G F Koob
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

2.  Focused microwave irradiation of the brain preserves in vivo protein phosphorylation: comparison with other methods of sacrifice and analysis of multiple phosphoproteins.

Authors:  James P O'Callaghan; Krishnan Sriram
Journal:  J Neurosci Methods       Date:  2004-05-30       Impact factor: 2.390

Review 3.  MAPK cascade signalling and synaptic plasticity.

Authors:  Gareth M Thomas; Richard L Huganir
Journal:  Nat Rev Neurosci       Date:  2004-03       Impact factor: 34.870

Review 4.  Molecular mechanisms of drug reinforcement and addiction.

Authors:  D W Self; E J Nestler
Journal:  Annu Rev Neurosci       Date:  1995       Impact factor: 12.449

5.  Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal.

Authors:  S.C. Heinrichs; F. Menzaghi; G. Schulteis; G.F. Koob; L. Stinus
Journal:  Behav Pharmacol       Date:  1995-01       Impact factor: 2.293

6.  Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus.

Authors:  R S Duman; J F Tallman; E J Nestler
Journal:  J Pharmacol Exp Ther       Date:  1988-09       Impact factor: 4.030

7.  Protein kinases in the rat nucleus accumbens are involved in the aversive component of opiate withdrawal.

Authors:  O Valverde; E Tzavara; J Hanoune; B P Roques; R Maldonado
Journal:  Eur J Neurosci       Date:  1996-12       Impact factor: 3.386

8.  Morphine and naloxone, i.p. or locally, affect extracellular acetylcholine in the accumbens and prefrontal cortex.

Authors:  P V Rada; G P Mark; K M Taylor; B G Hoebel
Journal:  Pharmacol Biochem Behav       Date:  1996-04       Impact factor: 3.533

9.  A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat.

Authors:  J R Taylor; L J Punch; J D Elsworth
Journal:  Psychopharmacology (Berl)       Date:  1998-07       Impact factor: 4.530

Review 10.  Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system.

Authors:  David W Self
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

View more
  24 in total

1.  Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence-induced hyperalgesia.

Authors:  Paula E Park; Joel E Schlosburg; Leandro F Vendruscolo; Gery Schulteis; Scott Edwards; George F Koob
Journal:  Addict Biol       Date:  2013-12-13       Impact factor: 4.280

2.  Opiate Exposure State Controls a D2-CaMKIIα-Dependent Memory Switch in the Amygdala-Prefrontal Cortical Circuit.

Authors:  Laura G Rosen; Jordan Zunder; Justine Renard; Jennifer Fu; Walter Rushlow; Steven R Laviolette
Journal:  Neuropsychopharmacology       Date:  2015-07-15       Impact factor: 7.853

3.  The affective dimension of pain as a risk factor for drug and alcohol addiction.

Authors:  Dana M LeBlanc; M Adrienne McGinn; Christy A Itoga; Scott Edwards
Journal:  Alcohol       Date:  2015-05-01       Impact factor: 2.405

4.  Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome.

Authors:  Ashish K Rehni; Nirmal Singh; Mahesh Rachamalla; Kulbhushan Tikoo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-02-25       Impact factor: 3.000

5.  Calcium/calmodulin-dependent protein kinase II mediates hippocampal glutamatergic plasticity during benzodiazepine withdrawal.

Authors:  Guofu Shen; Bradley J Van Sickle; Elizabeth I Tietz
Journal:  Neuropsychopharmacology       Date:  2010-05-05       Impact factor: 7.853

6.  Protein kinase C phosphorylates the cAMP response element binding protein in the hypothalamic paraventricular nucleus during morphine withdrawal.

Authors:  F Martín; L Mora; Ml Laorden; Mv Milanés
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

7.  Development of mechanical hypersensitivity in rats during heroin and ethanol dependence: alleviation by CRF₁ receptor antagonism.

Authors:  Scott Edwards; Leandro F Vendruscolo; Joel E Schlosburg; Kaushik K Misra; Sunmee Wee; Paula E Park; Gery Schulteis; George F Koob
Journal:  Neuropharmacology       Date:  2011-11-23       Impact factor: 5.250

Review 8.  Molecular and genetic substrates linking stress and addiction.

Authors:  Lisa A Briand; Julie A Blendy
Journal:  Brain Res       Date:  2009-11-10       Impact factor: 3.252

9.  Corticotropin-releasing factor (CRF) and α 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats.

Authors:  Paula E Park; Leandro F Vendruscolo; Joel E Schlosburg; Scott Edwards; Gery Schulteis; George F Koob
Journal:  Int J Neuropsychopharmacol       Date:  2013-04-16       Impact factor: 5.176

10.  Central amygdala GluA1 facilitates associative learning of opioid reward.

Authors:  You-Qing Cai; Wei Wang; Yuan-Yuan Hou; Zhi Zhang; Jun Xie; Zhizhong Z Pan
Journal:  J Neurosci       Date:  2013-01-23       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.